SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001493152-17-002272
Filing Date
2017-03-09
Accepted
2017-03-09 08:18:32
Documents
14
Period of Report
2017-03-09
Items
Item 2.02: Results of Operations and Financial Condition
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 form8-k.htm 8-K 27330
2 ex99-1.htm EX-99.1 74573
3 ex99-1_001.jpg GRAPHIC 3249
4 ex99-1_002.jpg GRAPHIC 3563
5 ex99-1_003.jpg GRAPHIC 3249
6 ex99-1_004.jpg GRAPHIC 3563
7 ex99-1_005.jpg GRAPHIC 3249
8 ex99-1_006.jpg GRAPHIC 3563
9 ex99-1_007.jpg GRAPHIC 3249
10 ex99-1_008.jpg GRAPHIC 3563
11 ex99-1_009.jpg GRAPHIC 3249
12 ex99-1_010.jpg GRAPHIC 3563
13 ex99-1_011.jpg GRAPHIC 3249
14 ex99-1_012.jpg GRAPHIC 3563
  Complete submission text file 0001493152-17-002272.txt   160868
Mailing Address 100 RIVER RIDGE DRIVE NORWOOD MA 02062
Business Address 100 RIVER RIDGE DRIVE NORWOOD MA 02062 617-963-0103
Corbus Pharmaceuticals Holdings, Inc. (Filer) CIK: 0001595097 (see all company filings)

IRS No.: 464348039 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-37348 | Film No.: 17676852
SIC: 2834 Pharmaceutical Preparations